Mason, OH, United States of America

Wenzhu (Steven) Zhao

This inventor holds 1 USPTO granted patent. Top assignee: The Procter Gamble Company. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenzhu (Steven) Zhao. Retrieved from https://idiyas.com/inventor/wenzhu-steven-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Wenzhu (Steven) Zhao - Revolutionizing Probiotics

Introduction: Wenzhu (Steven) Zhao, a brilliant inventor based in Mason, OH (US), has made remarkable contributions to the field of probiotics with his groundbreaking patent - Bifidobacterium longum.

Latest Patents: Wenzhu (Steven) Zhao holds 1 impressive patent for Bifidobacterium longum, which encompasses the genome of a probiotic bifidobacteria strain and the genes encoded by the genome, introducing various novel advancements in the field.

Career Highlights: Wenzhu (Steven) Zhao is a key member of the renowned company, The Procter & Gamble Company, where his innovative work has paved the way for cutting-edge developments in probiotics.

Collaborations: Throughout his career, Wenzhu (Steven) Zhao has collaborated closely with esteemed colleagues such as Douwe Van Sinderen and Jun Xu, enhancing the depth and impact of his research in probiotics.

Conclusion: Wenzhu (Steven) Zhao's pioneering work in probiotics, exemplified by his groundbreaking patent Bifidobacterium longum, showcases his unwavering commitment to advancing scientific innovations and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…